Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$3.5 - $5.68 $211,050 - $342,504
-60,300 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$3.44 - $6.37 $3.33 Million - $6.16 Million
-966,700 Reduced 94.13%
60,300 $312,000
Q2 2021

Aug 12, 2021

BUY
$3.86 - $5.78 $2.2 Million - $3.29 Million
569,500 Added 124.48%
1,027,000 $4.38 Million
Q1 2021

May 13, 2021

BUY
$4.9 - $6.83 $2.24 Million - $3.12 Million
457,500 New
457,500 $2.43 Million

Others Institutions Holding ADAP

About Adaptimmune Therapeutics PLC


  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $105M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.